Physiotherapy for persistent postnatal stress urinary incontinence : a randomized controlled trial by Dumoulin, Chantale et al.
Physiotherapy for Persistent Postnatal Stress Urinary Incontinence: A Randomized 
Controlled Trial 
Dumoulin, Chantale PhD, PT; Lemieux, Marie-Claude MD, FRCSC; Bourbonnais, Daniel PhD, OT; 
Gravel, Denis PhD, PT; Bravo, Gina PhD; Morin, Mélanie MSc, PT 
 
Author Information 
From the *School of Rehabilitation, Faculty of Medicine, University of Montreal, Montreal, Canada; 
†Rehabilitation Institute of Montreal, Research Center for Interdisciplinary Research in Rehabilitation of 
Montreal, Montreal, Canada; ‡Department of Obstetrics and Gynecology, Maisonneuve-Rosemont 
Hospital, Montreal, Canada; §Faculty of Medicine, University of Montreal, Montreal, Canada; 
¶Department of Community Health Sciences, Faculty of Medicine, University of Sherbrooke, Sherbrooke, 
Canada; and [//]Research Center on Aging, Sherbrooke University Geriatric Institute, Sherbrooke, Canada. 
Supported by the Canadian Institutes of Health Research and Laborie Medical Technologies Inc. through a 
Canadian Institutes of Health Research–Industry grant. C. Dumoulin was supported by studentships from 
the Canadian Institutes of Health Research and from the Fonds de la Recherche en Santé du Québec. 
The authors thank Dr. Robert Gauthier and members of the Department of Obstetrics and Gynecology of 
Sainte-Justine's Hospital in Montreal, Canada, for their assistance with data collection. 
Address reprint requests to: Chantale Dumoulin, Rehabilitation Institute of Montreal, Research Center for 
Interdisciplinary Research in Rehabilitation of Montreal, 6300 Darlington, Montreal, Quebec, Canada H3S 
2J4; e-mail:dumoulin@sympatico.ca. 
 
Received March 9, 2004. Received in revised form April 29, 2004. Accepted May 7, 2004. 
Abstract 
OBJECTIVE: The aim of this study was to compare the effectiveness of multimodal supervised 
physiotherapy programs with the absence of treatment among women with persistent postnatal stress 
urinary incontinence. 
METHODS: This was a single-blind randomized controlled trial. Sixty-four women with stress urinary 
incontinence were randomly assigned to 8 weeks of either multimodal pelvic floor rehabilitation (n = 21), 
multimodal pelvic floor rehabilitation with abdominal muscle training (n = 23), or control non–pelvic floor 
rehabilitation (n = 20). The primary outcome measure consisted of a modified 20-minute pad test. The 
secondary outcome measures included a Visual Analog Scale describing the perceived burden of 
incontinence, the Urogenital Distress Inventory, the Incontinence Impact Questionnaire, and pelvic floor 
muscle function measurements. 
RESULTS: Two patients dropped out, leaving 62 for analysis. At follow-up, more than 70% of the women 
in the treatment groups (14/20 in the pelvic floor and 17/23 in the pelvic floor plus abdominal group) were 
continent on pad testing compared with 0% of women in the control group. Scores on the pad test, Visual 
Analog Scale, Urogenital Distress Inventory, and Incontinence Impact Questionnaire improved 
significantly in both treatment groups (all P < .002), whereas no changes were observed in the control 
group. Pelvic floor muscle function, however, did not improve significantly in either active group. 
CONCLUSION: Multimodal supervised pelvic floor physiotherapy is an effective treatment for persistent 
postnatal stress urinary incontinence. 
LEVEL OF EVIDENCE: I 
 
 
Postnatal stress urinary incontinence is an important social and hygienic health problem affecting between 
3% and 24% of adult women.1,2 Those in whom stress urinary incontinence develops during pregnancy or 
puerperium without remission 3 months after delivery have a very high risk of symptom persistence 5 years 
later.3 Pelvic floor muscle physiotherapy is generally recommended to reduce postnatal urinary 
incontinence. This therapy involves graded muscle training, either alone or in combination with 
biofeedback, electrical stimulation, and vaginal cones and is designed to rehabilitate and strengthen the 
pelvic floor muscle.4 Although pelvic floor muscle physiotherapy after childbirth has proven effective in 
the prevention of urinary incontinence,5–8 few trials have addressed the treatment of persistent postnatal 
stress urinary incontinence.9,10 In addition, although these trials produced good results, the dropout rates 
were high (52% and 25%, respectively).9,10 
Recent experimental data suggest that deep abdominal exercises may be used to improve the effect of a 
pelvic floor muscle rehabilitation program.11,12 However, no clinical trial has evaluated their potentiating 
effects. 
This article reports the results of a randomized controlled trial in which the primary objective was to assess 
the effectiveness of pelvic floor muscle physiotherapy programs in the treatment of persistent postnatal 
stress urinary incontinence. The secondary objective was to compare pelvic floor rehabilitation programs 
with and without deep abdominal muscle training in the treatment of persistent postnatal stress urinary 
incontinence. 
 
MATERIALS AND METHODS 
Young parous women were recruited by means of a urinary incontinence questionnaire handed out at the 
obstetrics clinic of Sainte-Justine Hospital to patients during their annual gynecologic visit. If incontinence 
was reported, the women were screened by telephone to determine their eligibility. To be eligible, 
participants had to be younger than 45 years, premenopausal, still presenting symptoms of stress urinary 
incontinence at least once per week 3 months or more after their last delivery, and willing to participate in 
the study. Women who had experienced urinary incontinence before pregnancy, who had had previous 
surgery for stress incontinence, a neurologic or psychiatric disease, or a major medical condition, or those 
who were taking medication that could interfere with their evaluation or treatment were excluded. Current 
pregnancy and inability to understand French or English instructions were also causes for exclusion. 
A total of 120 potential participants met the initial criteria. The local ethics committee approved the study 
and all participants provided their written informed consent to enrollment. The study was conducted 
between January 2001 and April 2003. Subjects were scheduled for evaluation by a gynecologist. Those 
with moderate to severe urogenital prolapse (Pelvic Organ Prolapse Quantification System stage II or 
higher)13 were excluded. After remaining subjects emptied their bladders, the amount of residual urine was 
measured to exclude those with a high postvoid residual urine volume (more than 50 mL). The bladder was 
then refilled by catheter with 250 mL of sterile water at ambient room temperature. To confirm the 
diagnosis of stress urinary incontinence, subjects performed a 20-minute pad test, substituting 10 jumping 
jacks 14 for the standard jumping exercises.15 Those with less than 5 g of leakage measured by the 20-
minute pad test with fixed bladder volume were excluded. Urodynamic testing was then performed in the 
remaining candidates. Those with involuntary detrusor contraction on cystometry were excluded from the 
study. 
Sixty-four women were randomly allocated to a pelvic floor rehabilitation group, a pelvic floor 
rehabilitation plus abdominal training group, or a control group. Stratified randomization was performed 
using a balanced block randomization schedule generated from a table of random numbers.16 Because 
severity of incontinence and parity are factors that may affect the outcomes of treatment,4 subjects were 
stratified into 4 groups according to the results of the pad test (5–10 g of urine loss and more than 10 g of 
leakage) and parity (primipara and multipara). The evaluators and clinicians involved with the treatment 
groups had no access to the randomization procedure. A research investigator who was not involved in any 
intervention or outcome assessment informed all participants of their group allocation, which was 
preestablished by the randomization schedule. The participants were asked not to disclose their group 
allocation to the evaluators. 
Five physiotherapists were trained to conduct both standardized reeducation programs. The women in the 
pelvic floor rehabilitation group had weekly sessions under the supervision of an experienced 
physiotherapist for 8 consecutive weeks. Each session consisted of a 15-minute electrical stimulation of the 
pelvic floor muscle (stimulating-current characteristics: biphasic rectangular form; frequency 50 Hz; pulse 
width 250 microseconds; duty cycle, 6 seconds on and 18 seconds off for the first 4 weeks and 8 seconds 
on and 24 seconds off for the last 4 weeks; maximal tolerated current intensity 14), followed by a 25-
minute pelvic floor muscle exercise program with biofeedback, which included strengthening and motor 
relearning exercises,17,18 and a home exercise program to be done 5 days per week.17,18 The UROSTIM 
Unit (Laborie Medical Technologies, Brossard, Quebec, Canada) was used for the electrical stimulation 
and electromyographic biofeedback during the whole supervised treatment. 
The women in the pelvic floor rehabilitation plus abdominal training group followed weekly sessions under 
the supervision of an experienced physiotherapist for 8 consecutive weeks. Each session consisted of the 
multimodal pelvic floor rehabilitation protocol described previously plus 30 minutes of deep abdominal 
muscle training consisting of isolation, reeducation, and functional retraining of the transversus 
abdominis.19 Complete deep abdominal muscle training protocols are available from the first author. 
The women in the control group had 8 weekly sessions of relaxation massage for the back and extremities 
performed by a physiotherapist. They were asked not to exercise their pelvic floor muscles at home during 
the study, but were offered the possibility of receiving a treatment at trial completion. 
The primary outcome measure consisted of a modified 20-minute pad test with standardized bladder 
volume.14 A nurse-assessor who was unaware of the treatment allocation of the participant administered 
the test twice, once during the initial evaluation and again the week after treatment ended. Participants with 
pad weight gains of less than 2 g were considered continent.14 
The secondary outcome consisted of 4 different measures. The subject's perceived burden of incontinence 
was evaluated using a Visual Analog Scale (VAS) that proved to be valid, reproducible, and responsive to 
treatment for urinary incontinence in women.20 Assessment of symptoms associated with incontinence was 
performed using a French version of the Urogenital Distress Inventory, a 19-item questionnaire about lower 
urinary tract symptoms.21Assessment of the psychological impact of urinary incontinence was performed 
using the French Canadian version of the Incontinence Impact Questionnaire, 26 items focusing on daily 
living, social interaction, sex life, and self-perception.22 Both questionnaires have acceptable levels of 
reliability, validity, and responsiveness and have been used in several clinical trials.21–23 
Finally, pelvic floor maximum strength and rapidity of contraction were measured using a new static pelvic 
floor muscle dynamometer 24 designed to evaluate the pelvic floor muscle function. The psychometric 
properties of the measurements taken with the new device have been studied in young parous women in a 
large research program, which included an acceptability study, a test-retest reliability trial, and a construct 
validity study.24–26 All secondary outcome measures were taken during the preintervention evaluation and 
during the postintervention evaluation the week after the intervention ended. 
The sample size was initially set at 29 subjects per group. This sample size would provide 80% power to 
detect a statistically significant group by time interaction effect at the .05 significance level if the active 
treatments induced medium to large effect sizes. The expected effect sizes were based on a pilot study on 
physiotherapy for postnatal stress urinary incontinence, with urine loss on the pad test as the primary 
outcome measure.13 In that study, we observed a difference in the pretreatment and posttreatment mean of 
the order of 0.60 standard deviation, which corresponds to a medium-to-large effect.27 
Analysis was done on data from treated participants, excluding those without a final evaluation of the 
outcome variables. First, the experimental and control groups were compared for background (age, body 
mass index, parity, duration of symptoms) and outcome variables to determine the comparability of the 
groups at baseline. A nonparametric Kruskal-Wallis test was used because several outcome variables were 
not normally distributed and sample sizes were small. Pretreatment and posttreatment scores for primary 
and secondary outcome measures were compared to evaluate change in each of the three groups with the 
Wilcoxon signed rank test. Then, the change scores (pretreatment - posttreatment scores) for the 
experimental and control groups were compared to determine whether they varied between groups. The 
Kruskal-Wallis test was performed for this purpose. Finally, the Mann-Whitney test was used to detect 
differences between the control group and each experimental group and between each experimental group. 
Two-tailed P values of .05 were considered statistically significant. All analyses were performed using 
SPSS 11.0 (SPSS Inc., Chicago, IL). 
 
RESULTS 
Pad test scores improved significantly (P < .001) in both the pelvic floor and the pelvic floor plus 
abdominal treatment groups but not in the control group (P = .243). More than 70% of the women 
in both treatment groups (14/20 in the pelvic floor group and 17/23 in the pelvic floor plus 
abdominal group) showed objective cure as defined by less than 2 g urine on the pad test, whereas 
none in the control group were cured (Fig. 2). Approximately 90% of the women in the active 
treatment groups showed a greater than 50% reduction in leakage compared with 10% among the 
women in the control group (Fig. 2). Scores on the VAS, Urogenital Distress Inventory, and the 
Incontinence Impact Questionnaire improved significantly (all P < .002) in both treatment groups 
but not in the control group (all P > .589). However, the pelvic floor muscle maximum strength and 
rapidity of contraction did not improve significantly in any of the 3 groups. 
 
Statistical analyses comparing change scores among the 3 groups showed statistically significant 
results for all outcome measures (all P < .028) except the pelvic floor muscle function tests. In 
addition, there were statistically significant differences in scores on the pad test, VAS, Urogenital 
Distress Inventory, and Incontinence Impact Questionnaire in 2 compared groups: control versus 
pelvic floor (all P < .019) and control versus pelvic floor plus abdominal (all P < .021) (Table 3). 
No statistically significant difference in change scores was observed, however, for scores on the 
pad test, VAS, Urogenital Distress Inventory, and Incontinence Impact Questionnaire between the 2 
treatment groups. 
 
No adverse effects or difficulty using electrical stimulation were reported by the subjects of this study. 
Finally, the results of the intention-to-treat analyses were virtually the same as those of the treatment 
analysis for all outcomes. 
 
Fig. 1. Trial profiles showing the flow of participants through each stage of the randomized trial comparing trainings 
and control groups.Dumoulin. Treating Persistent Postnatal Incontinence. Obstet Gynecol 2004. 
 
 
 
Fig. 2. Objective cure (less than 2 g of leakage on the pad test with standardized bladder volume) and percentage of 
reduction of urine after treatment.Dumoulin. Treating Persistent Postnatal Incontinence. Obstet Gynecol 2004. 
 
 
 
  
 
 
 
 
 
 
DISCUSSION 
Multimodal supervised pelvic floor physiotherapy reduces persistent postnatal stress urinary incontinence. 
This study demonstrates that multimodal supervised pelvic floor physiotherapy programs are more 
effective than no treatment in parous women with persistent stress urinary incontinence. The choice of a 
control group in which no treatment was offered was made in terms of the population studied; namely, 
women with persistent postnatal stress urinary incontinence 3 or more months after delivery who could 
show a spontaneous reduction of symptoms with time. By giving massage to the control group, we 
controlled for the response of subjects to the special attention they received from physiotherapists. 
Our results corroborate those from the randomized controlled trials of Wilson and Herbison 9 and Glazener 
et al,10 who reported that 7 and 9 months of pelvic floor rehabilitation significantly reduced persistent 
stress urinary incontinence. In-depth comparison between the results of the present study and those of the 
previous studies is difficult, because the training protocol and its duration differed among studies. 
It is important to point out that marked objective and subjective improvement in continence status was 
observed after only 8 weeks of pelvic floor rehabilitation with high adherence to treatment. Our dropout 
rate was only 6% compared with 52% in Wilson and Herbison's study and 25% in Glazener et al's study. 
Interestingly, more than 30% of the withdrawals from Wilson and Herbison's study 9 were related to time 
constraints and work. It is possible that the much shorter intervention time and close supervision of the 
intervention by a trained physiotherapist in our study contributed to the patients’ strong adherence to the 
treatment. We recognize, however, that the extent of symptom duration after delivery was somewhat 
different from that in the study by Wilson and Herbison and Glazener et al, which may also have 
contributed to the difference in dropout rates. 
Many factors may have contributed to the marked objective and subjective improvement in continence 
status observed in a shorter period. First, pelvic floor muscle exercises conducted under the close 
supervision of a trained professional have proven more effective than pelvic floor exercises performed at 
home.4 In addition, the present protocol, with the use of electrical stimulation, biofeedback in conjunction 
with pelvic floor muscle training, and timed pelvic floor contractions, may have contributed to rapid 
continence improvement. However, the relative contribution of each factor cannot be determined in our 
study. Whether these results will translate into long-term cure or improvement of persistent posturinary 
stress incontinence is unknown at this point. 
Although the objective and subjective continence outcomes improved significantly after implementation of 
both pelvic floor rehabilitation programs, it appears that these effects are not related directly to changes in 
the pelvic floor muscle function. Factors other than strength and rapidity of contraction may have 
contributed to continence. Motor learning phenomena not related to change in maximal strength, such as 
better timing of the pelvic floor contraction and increased perception of pelvic muscle contraction 
encouraged by the present rehabilitation protocol, may have contributed to the rapid change in continence 
status. Nonetheless, the results do not exclude the possibility that the small sample size in this study (n = 
20, n = 23, and n = 19) was a limiting factor and that any nonsignificant results may be due to type II 
errors. A larger sample size would be needed to make a good pelvic floor muscle function comparison 
between groups. 
Finally, the present results suggest that the addition of abdominal training does not further improve the 
outcome of pelvic floor muscle rehabilitation. Although we were unable to recruit 29 subjects per group as 
planned initially, the improvement in the pelvic floor group as measured by the pad test was higher than 
expected, making additional improvement in the pelvic floor rehabilitation plus abdominal training group 
virtually undetectable and clinically nonsignificant. 
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